Literature DB >> 23995780

Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR+ CXC chemokines.

Viktor A Adalsteinsson1, Narmin Tahirova, Naren Tallapragada, Xiaosai Yao, Liam Campion, Alessandro Angelini, Thomas B Douce, Cindy Huang, Brittany Bowman, Christina A Williamson, Douglas S Kwon, K Dane Wittrup, J Christopher Love.   

Abstract

Cancer is an inflammatory disease of tissue that is largely influenced by the interactions between multiple cell types, secreted factors, and signal transduction pathways. While single-cell sequencing continues to refine our understanding of the clonotypic heterogeneity within tumors, the complex interplay between genetic variations and non-genetic factors ultimately affects therapeutic outcome. Much has been learned through bulk studies of secreted factors in the tumor microenvironment, but the secretory behavior of single cells has been largely uncharacterized. Here we directly profiled the secretions of ELR+ CXC chemokines from thousands of single colorectal tumor and stromal cells, using an array of subnanoliter wells and a technique called microengraving to characterize both the rates of secretion of several factors at once and the numbers of cells secreting each chemokine. The ELR+ CXC chemokines are highly redundant, pro-angiogenic cytokines that signal via the CXCR1 and CXCR2 receptors, influencing tumor growth and progression. We find that human primary colorectal tumor and stromal cells exhibit polyfunctional heterogeneity in the combinations and magnitudes of secretions for these chemokines. In cell lines, we observe similar variance: phenotypes observed in bulk can be largely absent among the majority of single cells, and discordances exist between secretory states measured and gene expression for these chemokines among single cells. Together, these measures suggest secretory states among tumor cells are complex and can evolve dynamically. Most importantly, this study reveals new insight into the intratumoral phenotypic heterogeneity of human primary tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995780      PMCID: PMC4034677          DOI: 10.1039/c3ib40059j

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  38 in total

Review 1.  Chemokines: multiple levels of leukocyte migration control.

Authors:  Bernhard Moser; Marlene Wolf; Alfred Walz; Pius Loetscher
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  A microengraving method for rapid selection of single cells producing antigen-specific antibodies.

Authors:  J Christopher Love; Jehnna L Ronan; Gijsbert M Grotenbreg; Annemarthe G van der Veen; Hidde L Ploegh
Journal:  Nat Biotechnol       Date:  2006-05-14       Impact factor: 54.908

4.  The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.

Authors:  Yan Ning; Melissa J Labonte; Wu Zhang; Pierre O Bohanes; Armin Gerger; Dongyun Yang; Leonor Benhaim; David Paez; David O Rosenberg; Kalyan C Nagulapalli Venkata; Stan G Louie; Nicos A Petasis; Robert D Ladner; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2012-03-05       Impact factor: 6.261

5.  Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving.

Authors:  Qing Han; Elizabeth M Bradshaw; Björn Nilsson; David A Hafler; J Christopher Love
Journal:  Lab Chip       Date:  2010-04-08       Impact factor: 6.799

Review 6.  Chemotaxis in cancer.

Authors:  Evanthia T Roussos; John S Condeelis; Antonia Patsialou
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

7.  Tumour evolution inferred by single-cell sequencing.

Authors:  Nicholas Navin; Jude Kendall; Jennifer Troge; Peter Andrews; Linda Rodgers; Jeanne McIndoo; Kerry Cook; Asya Stepansky; Dan Levy; Diane Esposito; Lakshmi Muthuswamy; Alex Krasnitz; W Richard McCombie; James Hicks; Michael Wigler
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

8.  Chemokines in human colorectal carcinoma.

Authors:  P K Baier; S Eggstein; G Wolff-Vorbeck; U Baumgartner; U T Hopt
Journal:  Anticancer Res       Date:  2005 Sep-Oct       Impact factor: 2.480

9.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

10.  Screening individual hybridomas by microengraving to discover monoclonal antibodies.

Authors:  Adebola O Ogunniyi; Craig M Story; Eliseo Papa; Eduardo Guillen; J Christopher Love
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more
  8 in total

1.  Dynamic secretome of bone marrow-derived stromal cells reveals a cardioprotective biochemical cocktail.

Authors:  David D Ellison; Yasir Suhail; Junaid Afzal; Laura Woo; Onur Kilic; Jeffrey Spees; Andre Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

Review 2.  Targeting minimal residual disease: a path to cure?

Authors:  Marlise R Luskin; Mark A Murakami; Scott R Manalis; David M Weinstock
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

3.  Towards Engineered Processes for Sequencing-Based Analysis of Single Circulating Tumor Cells.

Authors:  Viktor A Adalsteinsson; J Christopher Love
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

Review 4.  Development of Microfluidic Systems Enabling High-Throughput Single-Cell Protein Characterization.

Authors:  Beiyuan Fan; Xiufeng Li; Deyong Chen; Hongshang Peng; Junbo Wang; Jian Chen
Journal:  Sensors (Basel)       Date:  2016-02-16       Impact factor: 3.576

5.  Microfluidic enrichment for the single cell analysis of circulating tumor cells.

Authors:  Trifanny Yeo; Swee Jin Tan; Chew Leng Lim; Dawn Ping Xi Lau; Yong Wei Chua; Sai Sakktee Krisna; Gopal Iyer; Gek San Tan; Tony Kiat Hon Lim; Daniel S W Tan; Wan-Teck Lim; Chwee Teck Lim
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

6.  Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells.

Authors:  Robert C Fisher; Kishan Bellamkonda; L Alex Molina; Shao Xiang; David Liska; Samaneh K Sarvestani; Susmita Chakrabarti; Annamarie Berg; Marda L Jorgensen; Denise Hatala; Sugong Chen; Alexandra Aiello; Henry D Appelman; Edward W Scott; Emina H Huang
Journal:  Neoplasia       Date:  2019-02-07       Impact factor: 5.715

Review 7.  Single-Cell RNA Sequencing for Analyzing the Intestinal Tract in Healthy and Diseased Individuals.

Authors:  Hua Yan; Yumeng Ye; HanZheng Zhao; Hongyan Zuo; Yang Li
Journal:  Front Cell Dev Biol       Date:  2022-07-07

8.  Automated rare single cell picking with the ALS cellcelector™.

Authors:  Constantin Nelep; Jens Eberhardt
Journal:  Cytometry A       Date:  2018-09-05       Impact factor: 4.355

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.